Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive publishing date : 2021 - 03 - 24 save search
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 15, 2021
Published: 2021-03-24 (Crawled : 21:00) - globenewswire.com
NDAQ | $60.075 0.11% 0.11% 2.3M
|
Finance
|
| O: 0.13%
H: 0.0%
C: -0.64%
positive nasdaq
Touax: 2020 RESULTS Solid operating and financial performance in 2020 and positive outlook for 2021
Published: 2021-03-24 (Crawled : 17:00) - globenewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 1.26%
H: 0.21%
C: -10.41%
positive results
Expectations for the Future of Gold Remain Positive
Published: 2021-03-24 (Crawled : 13:15) - prnewswire.com
KGC | $6.51 1.4% 0.14% 16M
|
Non-Energy Minerals
|
| O: -0.15%
H: 0.37%
C: -1.19%
HL | $5.28 0.74% 6.3M
|
Non-Energy Minerals
|
| O: 2.03%
H: 1.49%
C: -5.14%
FSM | $4.51 -1.31% 0.22% 3.9M
|
Non-Energy Minerals
|
| O: 1.2%
H: 0.0%
C: -3.4%
EGO | $14.9 -0.4% 0.01% 840K
|
Non-Energy Minerals
|
| O: 1.09%
H: 0.0%
C: -2.87%
RGLD 4 | $121.66 -1.09% -1.1% 460K
|
Non-Energy Minerals
|
| O: 0.38%
H: 0.65%
C: -1.36%
positive
Lexaria Technology Generates Positive Stability Testing for World-Class Ready-to-Drink CBD Beverages
Published: 2021-03-24 (Crawled : 12:00) - biospace.com/
LEXX | $2.25 -3.85% -4.0% 120K
|
Health Technology
|
| O: 5.02%
H: 4.19%
C: -5.49%
test positive technology
ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials
Published: 2021-03-24 (Crawled : 12:00) - globenewswire.com
PRQR | $1.86 -2.11% -2.15% 180K
|
Health Technology
|
| O: 7.22%
H: 5.87%
C: -1.9%
positive results positive results trial syndros
Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors
Published: 2021-03-24 (Crawled : 12:00) - globenewswire.com
THTX | $1.32 -12.78% 10K
|
Health Technology
|
| O: 0.84%
H: 2.5%
C: -3.61%
solid tumors phase 1 positive trial phase 3 phase 2
BrainStorm Announces Positive Topline Data in Phase 2 Study Evaluating NurOwn® as a Treatment for Progressive MS
Published: 2021-03-24 (Crawled : 12:00) - biospace.com/
BCLI | $0.503 -6.99% -7.51% 1.1M
|
Health Technology
|
| O: 18.62%
H: 2.15%
C: -13.12%
treatment phase 2 positive topline
Myovant Sciences and Pfizer Announce Positive Data from Phase 3 LIBERTY Randomized Withdrawal Study of Once-Daily Relugolix Combination Therapy in Women with Uterine Fibroids
Published: 2021-03-24 (Crawled : 11:00) - globenewswire.com
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.34%
H: 1.27%
C: 0.37%
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: 0.3%
H: 1.17%
C: -7.12%
positive therapy women phase 3
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.